Navigation Links
Oregon researchers discover a mechanism leading to cleft palate

By creating a genetic mutation in zebrafish, University of Oregon scientists say they've discovered a previously unknown mechanism for cleft palate, a common birth defect in humans that has challenged medical professionals for centuries.

Many molecular pathways in zebrafish are present in humans and other vertebrates. By studying the induced mutation in zebrafish, the 10-member research team isolated a disruption in early developmental signaling involving Pdgf, a platelet-derived growth-factor protein, and a microRNA known as Mirn140, the researchers write in a paper posted online in advance of regular publication the monthly journal Nature Genetics.

Mutant zebrafish lacking Pdgf had cleft palate similar to many human babies, showing that this growth factor helps to organize cells that make the palate. It came as a surprise that zebrafish into which the investigators had injected too much Mirn140 also had cleft palate.

MicroRNAs are small gene products, found to be involved in gene expression, that were first described in 1993 by researchers at Harvard University. The term microRNA was introduced in when these single-strand RNA molecules about nucleotides in length were more fully detailed in Science in October 2001 by Gary Ruvkun of Massachusetts General Hospital in Boston.

Mirn140, when operating normally, allows for normal cell signaling by the Pdgfra protein that properly triggers cell migrations necessary for correct oral-cranial building. The researchers showed that Mirn140 blocks the cell’s expression of Pdgfra. Thus, cleft palate can result from too little Pdgfra that occurs because of either a mutation in the Pdgfra gene or too much Mirn140.

"We showed that this microRNA regulates the expression of the gene by controlling the migration of precursor cells to the palate-forming area," said principal investigator John H. Postlethwait, a professor of biology and member of the UO's Institute of Molecular Biology and Institute of Neuroscience. "This is a novel mechanism never before described."

A cleft palate is an opening in the roof of the mouth in which the two sides of the palate did not fuse, or join together, during a baby's early development. Cleft palate can negatively affect speech production, feeding, maxillofacial growth and dentition.

The first known attempt to correct the defect occurred in 500 A.D. The defect occurs with or without cleft lip (a separation of the two sides of the lip), on average, in 1 in 600 newborns, according to the Cleft Palate Foundation, but can vary by race. The highest incidence (3.6 per 1,000 births) occurs in American Indians. Palate formation begins after five weeks of gestation in humans and defects can become visible at 17 weeks, according to WebMD’s eMedicine.

The findings provide a new window into the mechanisms involved in cleft palate and craniofacial defects, but researchers caution that the findings don't point toward new clinical applications.

"Further exploration of how microRNAs and other factors modulate signaling pathways such as the Pdgf pathway during palatogenesis will assuredly continue to provide insights into the cause of, and possible treatments for, human craniofacial disease," the authors conclude.


Contact: Jim Barlow
University of Oregon

Related medicine news :

1. Oregon researchers find trigger gene for muscle development
2. TriWest Contributes $30,000 to Oregon National Guard Fund
3. Tobacco Industry Puts Profits Before Kids in Defeating Oregon Ballot Initiative
4. Big Tobacco Spends Record $12 Million to Deceive Oregon Voters
5. New Report: Increasing Oregons Cigarette Tax Will Reduce Smoking, Save Lives and Save Money
6. The First Mega-Shelter Arrangement in Oregon Created for Major Disaster Response and Recovery
7. Details of Oregon Wine Regions First Luxury Inn, Spa Revealed at Groundbreaking Ceremony
8. Big Tobaccos Latest Dirty Trick: Deceiving Oregon Voters
9. Oregon Scientific to Sponsor First-Ever Rock Concert on Mount Everest
10. Contents of the McGinnis Mansion Refurbishes Portland, Oregon Sexual Minority Youth Center
11. The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers
Post Your Comments:
Related Image:
Oregon researchers discover a mechanism leading to cleft palate
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term ... long-term care insurance companies have a waiver for care if the client has a ... when the family pays for care, is often waived, so the benefits from their ...
(Date:10/13/2017)... ... ... Ellevate Network, the leading network for professional women, brought together some of ... their inaugural Summit in New York City in June. The event was livestreamed with ... 3 million. To watch the Mobilize Women video, click here . , ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: